Citations (117)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Yu Wang, Yingying Wang, Zhiyuan Qin, Sheng Cai, Lushan Yu, Haihong Hu & Su Zeng. (2021) The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 291-306.
Read now
Read now
Yingdan Huang, Xiuli Hong, Jiasheng Hu & Quanyi Lu. (2017) Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02. OncoTargets and Therapy 10, pages 3233-3239.
Read now
Read now
Takeshi Hirota, Toshihiro Tanaka, Hiroaki Takesue & Ichiro Ieiri. (2017) Epigenetic regulation of drug transporter expression in human tissues. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 19-30.
Read now
Read now
Elena Arrigoni, Sara Galimberti, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2016) ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1419-1432.
Read now
Read now
Ágota Apáti, Kornélia Szebényi, Zsuzsa Erdei, György Várady, Tamás I Orbán & Balázs Sarkadi. (2016) The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation. Expert Opinion on Drug Metabolism & Toxicology 12:1, pages 77-92.
Read now
Read now
Shuo Chen, Jin-Wen Jiao, Kai-Xuan Sun, Zhi-Hong Zong & Yang Zhao. (2015) MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Drug Design, Development and Therapy 9, pages 5225-5235.
Read now
Read now
Olivier LeTonqueze, Ju Lee & Shobha Vasudevan. (2012) MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells. RNA Biology 9:6, pages 871-880.
Read now
Read now
Igor Koturbash, Frederick A Beland & Igor P Pogribny. (2012) Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants. Expert Opinion on Drug Metabolism & Toxicology 8:5, pages 597-606.
Read now
Read now
Curtis D. Klaassen, Hong Lu & Julia Yue Cui. (2011) Epigenetic regulation of drug processing genes. Toxicology Mechanisms and Methods 21:4, pages 312-324.
Read now
Read now
Radu Albulescu, Monica Neagu, Lucian Albulescu & Cristiana Tanase. (2011) Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Review of Molecular Diagnostics 11:1, pages 101-120.
Read now
Read now
Miao Hu, Kenneth KW To, Valiant WL Mak & Brian Tomlinson. (2011) The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opinion on Drug Metabolism & Toxicology 7:1, pages 49-62.
Read now
Read now
Ai-Ming Yu. (2009) Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opinion on Drug Metabolism & Toxicology 5:12, pages 1513-1528.
Read now
Read now
Yi An & Weg M Ongkeko. (2009) ABCG2: the key to chemoresistance in cancer stem cells?. Expert Opinion on Drug Metabolism & Toxicology 5:12, pages 1529-1542.
Read now
Read now
Articles from other publishers (104)
Lindsey A. Starr, Luke E. McKay, Kylie N. Peter, Lena M. Seyfarth, Laura A. Berkowitz, Kim A. Caldwell & Guy A. Caldwell. (2023) Attenuation of Dopaminergic Neurodegeneration in a C. elegans Parkinson’s Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2. Journal of Developmental Biology 11:2, pages 20.
Crossref
Crossref
Manasi S. Pote & Rajesh N. Gacche. (2023) ATP-binding cassette efflux transporters and MDR in cancer. Drug Discovery Today 28:5, pages 103537.
Crossref
Crossref
Daniela Damiani & Mario Tiribelli. (2023) ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. International Journal of Molecular Sciences 24:8, pages 7147.
Crossref
Crossref
Anmol Bhatia, Atul Kumar Upadhyay & Siddharth Sharma. (2022)
miRNAs
are now starring in “
No Time to Die
: Overcoming the chemoresistance in cancer”
. IUBMB Life 75:3, pages 238-256.
Crossref
Crossref
YINGYING WANG, YING ZHOU, YU WANG, LUSHAN YU & SU ZENG. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
573
603
.
Xiaomeng Sun, Jiani Chen, Xintao Chen, Qianmin Gao, Wei Chen, Xun Zou, Feng Zhang, Shouhong Gao, Shi Qiu, Xiaoqiang Yue, Houshan Yao, Xuan Liu & Mingming Li. (2022) A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs. Disease Markers 2022, pages 1-14.
Crossref
Crossref
Robert W. Robey, Sabrina Lusvarghi, Cindy H. Chau, Agnes Basseville, William D. Figg, Suresh V. Ambudkar & Susan E. Bates. 2022. Drug Transporters. Drug Transporters
235
256
.
Lucia Pavlíková, Mário Šereš, Albert Breier & Zdena Sulová. (2022) The Roles of microRNAs in Cancer Multidrug Resistance. Cancers 14:4, pages 1090.
Crossref
Crossref
Yoon-Jee Chae, Ji-Eun Chang, Mi-Kyung Lee, Juhee Lim, Kwang-Hee Shin & Kyeong-Ryoon Lee. (2021) Regulation of drug transporters by microRNA and implications in disease treatment. Journal of Pharmaceutical Investigation 52:1, pages 23-47.
Crossref
Crossref
Neeraja K. Mohanan, Feba Shaji, Ganesh R. Koshre & Rakesh S. Laishram. (2021) Alternative polyadenylation: An enigma of transcript length variation in health and disease. WIREs RNA 13:1.
Crossref
Crossref
Samiksha Kukal, Debleena Guin, Chitra Rawat, Shivangi Bora, Manish Kumar Mishra, Priya Sharma, Priyanka Rani Paul, Neha Kanojia, Gurpreet Kaur Grewal, Shrikant Kukreti, Luciano Saso & Ritushree Kukreti. (2021) Multidrug efflux transporter ABCG2: expression and regulation. Cellular and Molecular Life Sciences 78:21-22, pages 6887-6939.
Crossref
Crossref
Meike Kaehler & Ingolf Cascorbi. (2021) Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia. Frontiers in Pharmacology 12.
Crossref
Crossref
Balázs Sarkadi, László Homolya & Tamás Hegedűs. (2020) The ABCG2/BCRP transporter and its variants – from structure to pathology. FEBS Letters 594:23, pages 4012-4034.
Crossref
Crossref
Jamie Nourse, Stefano Spada & Sven Danckwardt. (2020) Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders. Biomolecules 10:6, pages 915.
Crossref
Crossref
Daniella Kovacsics, Anna Brózik, Borbála Tihanyi, Zsolt Matula, Adrienn Borsy, Nikolett Mészáros, Edit Szabó, Eszter Németh, Ábel Fóthi, Boglárka Zámbó, Dávid Szüts, György Várady, Tamás I. Orbán, Ágota Apáti & Balázs Sarkadi. (2020) Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells. Biochemical Pharmacology 175, pages 113865.
Crossref
Crossref
Ming-Ju Hsieh, Chiao-Wen Lin, Shih-Chi Su, Russel J. Reiter, Andy Wei-Ge Chen, Mu-Kuan Chen & Shun-Fa Yang. (2020) Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells. Molecular Therapy - Nucleic Acids 19, pages 877-889.
Crossref
Crossref
Yan Dong, Yao Lin, Xiaotong Gao, Yingxin Zhao, Zhuo Wan, Haotian Wang, Mengying Wei, Xutao Chen, Weiwei Qin, Guodong Yang & Li Liu. (2019) Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib. Applied Microbiology and Biotechnology 103:23-24, pages 9569-9582.
Crossref
Crossref
García-Lino, Álvarez-Fernández, Blanco-Paniagua, Merino & Álvarez. (2019) Transporters in the Mammary Gland—Contribution to Presence of Nutrients and Drugs into Milk. Nutrients 11:10, pages 2372.
Crossref
Crossref
Reyhaneh Moradi Marjaneh, Majid Khazaei, Gordon A. Ferns, Amir Avan & Seyed Hamid Aghaee‐Bakhtiari. (2019) MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication. IUBMB Life 71:10, pages 1428-1441.
Crossref
Crossref
Yehuda G. Assaraf, Anamaria Brozovic, Ana Cristina Gonçalves, Dana Jurkovicova, Aija Linē, Miguel Machuqueiro, Simona Saponara, Ana Bela Sarmento-Ribeiro, Cristina P.R. Xavier & M. Helena Vasconcelos. (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resistance Updates 46, pages 100645.
Crossref
Crossref
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania & María Laura Ruiz. (2019) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 26:7, pages 1224-1250.
Crossref
Crossref
M Li, E L Seiser, R M Baldwin, J Ramirez, M J Ratain, F Innocenti & D L Kroetz. (2016) ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. The Pharmacogenomics Journal 18:1, pages 35-42.
Crossref
Crossref
Meike Kaehler, Johanna Ruemenapp, Daniel Gonnermann, Inga Nagel, Oliver Bruhn, Sierk Haenisch, Ole Ammerpohl, Daniela Wesch, Ingolf Cascorbi & Henrike Bruckmueller. (2017) MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells. Oncotarget 8:54, pages 92018-92031.
Crossref
Crossref
Martino Marco Gabra & Leonardo Salmena. (2017) microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview. Frontiers in Oncology 7.
Crossref
Crossref
Argha Manna, Shruti Banerjee, Poulami Khan, Apoorva Bhattacharya & Tanya Das. (2017) Contribution of nuclear events in generation and maintenance of cancer stem cells: revisiting chemo-resistance. The Nucleus 60:2, pages 121-135.
Crossref
Crossref
Kenneth K.W. To, Wing W. Leung & Simon S.M. Ng. (2017) A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development. Molecular Carcinogenesis 56:2, pages 464-477.
Crossref
Crossref
Scott G. Daniel, Atlantis D. Russ, Kathryn M. Guthridge, Ammad I. Raina, Patricia S. Estes, Linda M. Parsons, Helena E. Richardson, Joyce A. Schroeder & Daniela C. Zarnescu. (2017)
miR-9a
mediates the role of Lethal giant larvae as an epithelial growth inhibitor in
Drosophila
. Biology Open.
Crossref
Crossref
Xin An, Cesar Sarmiento, Tao Tan & Hua Zhu. (2017) Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharmaceutica Sinica B 7:1, pages 38-51.
Crossref
Crossref
Yuanzhang Fang, Lu Zhang, Zhenghu Li, Yujing Li, Cheng Huang & Xiongbin Lu. 2017. MiRNAs in Differentiation and Development. MiRNAs in Differentiation and Development
1
49
.
Dagmara Szkolnicka, Baltasar Lucendo-Villarin, Joanna K. Moore, Kenneth J. Simpson, Stuart J. Forbes & David C. Hay. (2016) Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs. Stem Cells Translational Medicine 5:6, pages 764-772.
Crossref
Crossref
Kai Wu, Yang Yang, Jia Zhao & Song Zhao. (2016) BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10. Cancer Letters 371:1, pages 125-133.
Crossref
Crossref
A.-M. Yu, Y. Tian, M.-J. Tu, P. Y. Ho & J. L. Jilek. (2015) MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy. Drug Metabolism and Disposition 44:3, pages 308-319.
Crossref
Crossref
HYUN-HYE MOON, SUNG-HEE KIM & JA-LOK KU. (2016) Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines. Oncology Reports 35:1, pages 298-306.
Crossref
Crossref
Kai-Xuan Sun, Jin-Wen Jiao, Shuo Chen, Bo-Liang Liu & Yang Zhao. (2015) MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1. Journal of Ovarian Research 8:1.
Crossref
Crossref
Yueping Zhan, Fenfen Xiang, Rong Wu, Jian Xu, Zhenhua Ni, Jiemin Jiang & Xiangdong Kang. (2015) MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88. Journal of Ovarian Research 8:1.
Crossref
Crossref
Kenneth K.W. To, W.W. Leung & Simon S.M. Ng. (2015) Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. Experimental Cell Research 338:2, pages 222-231.
Crossref
Crossref
Jennifer Bolleyn, Joery De Kock, Robim Marcelino Rodrigues, Mathieu Vinken, Vera Rogiers & Tamara Vanhaecke. (2014) MicroRNAs as key regulators of xenobiotic biotransformation and drug response. Archives of Toxicology 89:9, pages 1523-1541.
Crossref
Crossref
KS Burgess, S Philips, EA Benson, Z Desta, A Gaedigk, R Gaedigk, MW Segar, Y Liu & TC Skaar. (2015) Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver. Clinical Pharmacology & Therapeutics 98:2, pages 205-215.
Crossref
Crossref
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, Qiu-Xia Chen, Wei-Peng Wang, Patrick A. Limbach, Janine M. LaSalle, Su Zeng, Min Huang & Ai-Ming Yu. (2015)
Chimeric MicroRNA-1291 Biosynthesized Efficiently in
Escherichia coli
Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity
. Drug Metabolism and Disposition 43:7, pages 1129-1136.
Crossref
Crossref
Y He, J R Chevillet, G Liu, T K Kim & K Wang. (2015) The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs. British Journal of Pharmacology 172:11, pages 2733-2747.
Crossref
Crossref
Nirmalya Dasgupta, Bhupesh Kumar Thakur, Atri Ta & Santasabuj Das. (2015) Caveolin-1 is transcribed from a hypermethylated promoter to mediate colonocyte differentiation and apoptosis. Experimental Cell Research 334:2, pages 323-336.
Crossref
Crossref
Qingcheng Mao & Jashvant D. Unadkat. (2014) Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update. The AAPS Journal 17:1, pages 65-82.
Crossref
Crossref
Shuo Chen, Xi Chen, Yin-Ling Xiu, Kai-Xuan Sun, Zhi-Hong Zong & Yang Zhao. (2014) microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells. Journal of Ovarian Research 7:1.
Crossref
Crossref
Can Zong, Jun Wang & Tie-Mei Shi. (2014) MicroRNA 130b enhances drug resistance in human ovarian cancer cells. Tumor Biology 35:12, pages 12151-12156.
Crossref
Crossref
Mei-Mei Li, Wei-Peng Wang, Wen-Juan Wu, Min Huang & Ai-Ming Yu. (2014)
Rapid Production of Novel Pre-MicroRNA Agent hsa-mir-27b in
Escherichia coli
Using Recombinant RNA Technology for Functional Studies in Mammalian Cells
. Drug Metabolism and Disposition 42:11, pages 1791-1795.
Crossref
Crossref
Xiaolan Zhu, Yuefeng Li, Chanjuan Xie, Xinming Yin, Yueqin Liu, Yuan Cao, Yue Fang, Xin Lin, Yao Xu, Wenlin Xu, Huiling Shen & Jian Wen. (2014) miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. International Journal of Cancer 135:6, pages 1286-1296.
Crossref
Crossref
Jenny Wong. (2014) Regulation of a TrkB Alternative Transcript by microRNAs. Dementia and Geriatric Cognitive Disorders Extra 4:3, pages 364-374.
Crossref
Crossref
Agnes Basseville, Robert W. Robey, Julian C. Bahr & Susan E. Bates. 2014. Drug Transporters. Drug Transporters
187
221
.
Feng Li & Ram I. Mahato. (2014) MicroRNAs and Drug Resistance in Prostate Cancers. Molecular Pharmaceutics 11:8, pages 2539-2552.
Crossref
Crossref
Ke Shen, Rurong Mao, Li Ma, Yueqi Li, Yanyan Qiu, Daling Cui, Vanminh Le, Peihao Yin, Lei Ni & Jianwen Liu. (2014) Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. FEBS Journal 281:16, pages 3609-3624.
Crossref
Crossref
Anneke N. Werk, Henrike Bruckmueller, Sierk Haenisch & Ingolf Cascorbi. (2014) Genetic variants may play an important role in mRNA–miRNA interaction. Pharmacogenetics and Genomics 24:6, pages 283-291.
Crossref
Crossref
Andreas Gisel, Mirna Valvano, Imane El Idrissi, Patrizia Nardulli, Amalia Azzariti, Antonio Carrieri, Marialessandra Contino & Nicola Colabufo. (2014) miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives. Molecules 19:5, pages 5611-5623.
Crossref
Crossref
Sierk Haenisch, Anneke Nina Werk & Ingolf Cascorbi. (2014) MicroRNAs and their relevance to ABC transporters. British Journal of Clinical Pharmacology 77:4, pages 587-596.
Crossref
Crossref
Zhuo Dong, Zhiwei Zhong, Lihua Yang, Shaomin Wang & Zhaohui Gong. (2014) MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Letters 343:2, pages 249-257.
Crossref
Crossref
In-Wha Kim, Nayoung Han, Gilbert J. Burckart & Jung Mi Oh. (2014) Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:2, pages 140-150.
Crossref
Crossref
Sara Donzelli, Federica Mori, Francesca Biagioni, Teresa Bellissimo, Claudio Pulito, Paola Muti, Sabrina Strano & Giovanni Blandino. (2014) MicroRNAs: short non-coding players in cancer chemoresistance. Molecular and Cellular Therapies 2:1, pages 16.
Crossref
Crossref
Zhaohui Gong, Zhuo Dong, Lihua Yang, Jie Yang, Jingqiu Li, Yanping Le, Shaomin Wang, Meng Ye & Hui-Kuan Lin. 2014. MicroRNA Targeted Cancer Therapy. MicroRNA Targeted Cancer Therapy
51
82
.
Çiğir Biray Avci & Yusuf Baran. 2014. miRNomics: MicroRNA Biology and Computational Analysis. miRNomics: MicroRNA Biology and Computational Analysis
311
325
.
Kenneth KW To. (2013) MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy. Journal of Biomedical Science 20:1.
Crossref
Crossref
Magnus Ingelman-Sundberg, Xiao-Bo Zhong, Oliver Hankinson, Sudheer Beedanagari, Ai-Ming Yu, Lai Peng & Yoichi Osawa. (2013) Potential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport. Drug Metabolism and Disposition 41:10, pages 1725-1731.
Crossref
Crossref
Yu-Zhuo Pan, Amy Zhou, Zihua Hu & Ai-Ming Yu. (2013) Small Nucleolar RNA-Derived MicroRNA hsa-miR-1291 Modulates Cellular Drug Disposition through Direct Targeting of ABC Transporter ABCC1. Drug Metabolism and Disposition 41:10, pages 1744-1751.
Crossref
Crossref
Meng-Tao Ma, Miao He, Yan Wang, Xu-Yang Jiao, Lin Zhao, Xue-Feng Bai, Zhao-Jin Yu, Hui-Zhe Wu, Ming-Li Sun, Zhi-Guo Song & Min-Jie Wei. (2013) MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Cancer Letters 339:1, pages 107-115.
Crossref
Crossref
Michela Garofalo & Carlo M. Croce. (2013) MicroRNAs as therapeutic targets in chemoresistance. Drug Resistance Updates 16:3-5, pages 47-59.
Crossref
Crossref
Xuyang Jiao, Lin Zhao, Mengtao Ma, Xuefeng Bai, Miao He, Yuanyuan Yan, Yan Wang, Qiuchen Chen, Xinnan Zhao, Mingyi Zhou, Zeshi Cui, Zhihong Zheng, Enhua Wang & Minjie Wei. (2013) MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Research and Treatment 139:3, pages 717-730.
Crossref
Crossref
Y. Sun, Y. Fu, Y. Li & A. Xu. (2012) Genome-wide alternative polyadenylation in animals: insights from high-throughput technologies. Journal of Molecular Cell Biology 4:6, pages 352-361.
Crossref
Crossref
Yi An, Alan Kiang, Jay Patrick Lopez, Selena Z. Kuo, Michael Andrew Yu, Eric L. Abhold, Jocelyn S. Chen, Jessica Wang-Rodriguez & Weg M. Ongkeko. (2012) Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population. PLoS ONE 7:11, pages e47919.
Crossref
Crossref
Yun Chen, Ya-Hui Tsai, Yu Fang & Sheng-Hong Tseng. (2012) Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells. Journal of Pediatric Surgery 47:10, pages 1797-1805.
Crossref
Crossref
Raji Padmanabhan, Kevin G. Chen, Jean-Pierre Gillet, Misty Handley, Barbara S. Mallon, Rebecca S. Hamilton, Kyeyoon Park, Sudhir Varma, Michele G. Mehaffey, Pamela G. Robey, Ronald D. G. McKay & Michael M. Gottesman. (2012)
Regulation and Expression of the ATP-Binding Cassette Transporter
ABCG2
in Human Embryonic Stem Cells
. Stem Cells 30:10, pages 2175-2187.
Crossref
Crossref
Sierk Haenisch & Ingolf Cascorbi. (2012) miRNAs as mediators of drug resistance. Epigenomics 4:4, pages 369-381.
Crossref
Crossref
Grace M. Y. Cheng & Kenneth K. W. To. (2012) Adverse Cell Culture Conditions Mimicking the Tumor Microenvironment Upregulate ABCG2 to Mediate Multidrug Resistance and a More Malignant Phenotype. ISRN Oncology 2012, pages 1-10.
Crossref
Crossref
Benjamin Boyerinas, Sun-Mi Park, Andrea E. Murmann, Katja Gwin, Anton G. Montag, Marion Zillhardt, You-Jia Hua, Ernst Lengyel & Marcus E. Peter. (2012) Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. International Journal of Cancer 130:8, pages 1787-1797.
Crossref
Crossref
Anuradha Ramamoorthy, Lang Li, Andrea Gaedigk, L. DiAnne Bradford, Eric A. Benson, David A. Flockhart & Todd C. Skaar. (2012) In Silico and In Vitro Identification of MicroRNAs That Regulate Hepatic Nuclear Factor 4α Expression. Drug Metabolism and Disposition 40:4, pages 726-733.
Crossref
Crossref
Karthika Natarajan, Yi Xie, Maria R. Baer & Douglas D. Ross. (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochemical Pharmacology 83:8, pages 1084-1103.
Crossref
Crossref
Ai-Ming Yu & Yu-Zhuo Pan. (2012) Noncoding microRNAs: small RNAs play a big role in regulation of ADME?. Acta Pharmaceutica Sinica B 2:2, pages 93-101.
Crossref
Crossref
Elisa Giovannetti, Ayse Erozenci, Jorn Smit, Romano Danesi & Godefridus J. Peters. (2012) Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Critical Reviews in Oncology/Hematology 81:2, pages 103-122.
Crossref
Crossref
Alice C. Rodrigues, Xin Li, Laura Radecki, Yu-Zhuo Pan, Jerrold C. Winter, Min Huang & Ai-Ming Yu. (2011) MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. Biopharmaceutics & Drug Disposition 32:6, pages 355-367.
Crossref
Crossref
Sierk Haenisch, Sandra Laechelt, Henrike Bruckmueller, Anneke Werk, Andreas Noack, Oliver Bruhn, Cornelia Remmler & Ingolf Cascorbi. (2011) Down-Regulation of ATP-Binding Cassette C2 Protein Expression in HepG2 Cells after Rifampicin Treatment Is Mediated by MicroRNA-379. Molecular Pharmacology 80:2, pages 314-320.
Crossref
Crossref
Cheng-Fen Chen, Xiaolong He, Ahmet Dirim Arslan, Yin-Yuan Mo, William C. Reinhold, Yves Pommier & William T. Beck. (2011)
Novel Regulation of Nuclear Factor-YB by
miR-485-3p
Affects the Expression of DNA Topoisomerase IIα and Drug Responsiveness
. Molecular Pharmacology 79:4, pages 735-741.
Crossref
Crossref
K Moitra, H Lou & M Dean. (2011) Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development. Clinical Pharmacology & Therapeutics 89:4, pages 491-502.
Crossref
Crossref
Xin Li, Yu-Zhuo Pan, Gail M. Seigel, Zi-Hua Hu, Min Huang & Ai-Ming Yu. (2011) Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Biochemical Pharmacology 81:6, pages 783-792.
Crossref
Crossref
Rossella Rota, Roberta Ciarapica, Antonio Giordano, Lucio Miele & Franco Locatelli. (2011) MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Molecular Cancer 10:1, pages 120.
Crossref
Crossref
Erik A.C. Wiemer. 2011. MicroRNAs in Cancer Translational Research. MicroRNAs in Cancer Translational Research
449
483
.
Henriette E. Meyer zu Schwabedissen & Heyo K. Kroemer. 2011. Drug Transporters. Drug Transporters
325
371
.
Paul Cao, Zhiyong Deng, Meimei Wan, Weiwei Huang, Scott D Cramer, Jianfeng Xu, Ming Lei & Guangchao Sui. (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β. Molecular Cancer 9:1.
Crossref
Crossref
F Wang, X Xue, J Wei, Y An, J Yao, H Cai, J Wu, C Dai, Z Qian, Z Xu & Y Miao. (2010) hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. British Journal of Cancer 103:4, pages 567-574.
Crossref
Crossref
J Ma, C Dong & C Ji. (2010) MicroRNA and drug resistance. Cancer Gene Therapy 17:8, pages 523-531.
Crossref
Crossref
Dominique Cheneval, Tania Kastelic, Peter Fuerst & Christian N. Parker. (2010) A Review of Methods to Monitor the Modulation of mRNA Stability: A Novel Approach to Drug Discovery and Therapeutic Intervention. SLAS Discovery 15:6, pages 609-622.
Crossref
Crossref
Curtis Balch, Daniela E Matei, Tim H-M Huang & Kenneth P Nephew. (2010) Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2:3, pages 419-447.
Crossref
Crossref
Sook Wah Yee, Ligong Chen & Kathleen M Giacomini. (2010) Pharmacogenomics of membrane transporters: past, present and future. Pharmacogenomics 11:4, pages 475-479.
Crossref
Crossref
Xi-wei Ding, Jun-hua Wu & Chun-ping Jiang. (2010) ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sciences 86:17-18, pages 631-637.
Crossref
Crossref
Takeshi HIROTA, Ichiro IEIRI & Shun HIGUCHI. (2010) . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 41:3, pages 105S-106S.
Crossref
Crossref
Anna Maria Calcagno & Suresh V. Ambudkar. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer
77
93
.
Tongsen Zheng, Jiabei Wang, Xi Chen & Lianxin Liu. (2010) Role of microRNA in anticancer drug resistance. International Journal of Cancer 126:1, pages 2-10.
Crossref
Crossref
Eran E. Bram, Michal Stark, Shachar Raz & Yehuda G. Assaraf. (2009) Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance. Neoplasia 11:12, pages 1359-IN11.
Crossref
Crossref
Kenneth K.W. To, Robert W. Robey, Turid Knutsen, Zhirong Zhan, Thomas Ried & Susan E. Bates. (2009) Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Molecular Cancer Therapeutics 8:10, pages 2959-2968.
Crossref
Crossref
Yu-Zhuo Pan, Wenqing Gao & Ai-Ming Yu. (2009) MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting. Drug Metabolism and Disposition 37:10, pages 2112-2117.
Crossref
Crossref
XueMei Wu & HuaSheng Xiao. (2009) miRNAs modulate the drug response of tumor cells. Science in China Series C: Life Sciences 52:9, pages 797-801.
Crossref
Crossref
Aoife J Lowery, Nicola Miller, Amanda Devaney, Roisin E McNeill, Pamela A Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball & Michael J Kerin. (2009) MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer. Breast Cancer Research 11:3.
Crossref
Crossref
Yu-Zhuo Pan, Marilyn E. Morris & Ai-Ming Yu. (2009) MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells. Molecular Pharmacology 75:6, pages 1374-1379.
Crossref
Crossref
A Gomez & M Ingelman-Sundberg. (2009) Pharmacoepigenetics: Its Role in Interindividual Differences in Drug Response. Clinical Pharmacology & Therapeutics 85:4, pages 426-430.
Crossref
Crossref
Robert W. Robey, Kenneth K.K. To, Orsolya Polgar, Marius Dohse, Patricia Fetsch, Michael Dean & Susan E. Bates. (2009) ABCG2: A perspective. Advanced Drug Delivery Reviews 61:1, pages 3-13.
Crossref
Crossref
Gergely Szakács, Kenneth Kin Wah, Orsolya Polgár, Robert W. Robey & Susan E. Bates. 2009. Drug Resistance in Cancer Cells. Drug Resistance in Cancer Cells
1
20
.
William Kong, Jian-Jun Zhao, Lili He & Jin Q. Cheng. (2009) Strategies for profiling MicroRNA expression. Journal of Cellular Physiology 218:1, pages 22-25.
Crossref
Crossref
Ágota Apáti, Tamás I. Orbán, Nóra Varga, Andrea Németh, Anita Schamberger, Virág Krizsik, Boglárka Erdélyi-Belle, László Homolya, György Várady, Rita Padányi, Éva Karászi, Evelien W.M. Kemna, Katalin Német & Balázs Sarkadi. (2008) High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochimica et Biophysica Acta (BBA) - Biomembranes 1778:12, pages 2700-2709.
Crossref
Crossref